Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,715 | 82 | 97.2% |
| Education | $50.00 | 2 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $328.18 | 19 | $0 (2024) |
| Novo Nordisk Inc | $310.79 | 11 | $0 (2024) |
| Amgen Inc. | $220.24 | 13 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $128.05 | 7 | $0 (2024) |
| ABBVIE INC. | $103.87 | 4 | $0 (2024) |
| Exact Sciences Corporation | $103.45 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $87.38 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $68.24 | 3 | $0 (2023) |
| Lilly USA, LLC | $58.22 | 4 | $0 (2024) |
| ABIOMED | $55.44 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $635.30 | 33 | Amgen Inc. ($180.43) |
| 2023 | $693.71 | 34 | AstraZeneca Pharmaceuticals LP ($210.78) |
| 2022 | $436.41 | 17 | Novo Nordisk Inc ($212.28) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: Insulin Pump | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: Inflammation | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $39.51 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: RESPIRATORY | ||||||
| 07/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: Inflammation | ||||||
| 06/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Cardio-renal | ||||||
| 06/05/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: Inflammation | ||||||
| 05/11/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Neuromodulation | ||||||
| 05/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Inflammation | ||||||
| 04/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Inflammation | ||||||
| 04/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Obesity | ||||||
| 03/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardio-renal | ||||||
| 03/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Oncology | ||||||
| 03/20/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 39 | 72 | $576.00 | $227.20 |
| 2022 | 7 | 348 | 415 | $54,217 | $15,415 |
| 2021 | 10 | 575 | 740 | $95,973 | $28,846 |
| 2020 | 13 | 586 | 777 | $76,397 | $25,860 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 39 | 72 | $576.00 | $227.20 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 143 | $34,299 | $8,964 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 62 | $10,014 | $2,784 | 27.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 24 | 24 | $6,206 | $2,622 | 42.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,340 | $462.54 | 19.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 102 | 127 | $762.00 | $373.44 | 49.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 18 | 36 | $288.00 | $114.56 | 39.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $308.00 | $95.00 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 177 | 241 | $60,860 | $15,824 | 26.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 47 | 47 | $12,140 | $5,192 | 42.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 20 | 20 | $4,800 | $2,506 | 52.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 46 | $8,163 | $2,036 | 24.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $3,655 | $870.90 | 23.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 203 | 290 | $1,740 | $867.00 | 49.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $1,464 | $778.84 | 53.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 21 | 21 | $1,281 | $299.92 | 23.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 20 | 30 | $894.00 | $255.81 | 28.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 15 | 16 | $976.00 | $215.68 | 22.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 154 | 208 | $39,644 | $11,615 | 29.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 70 | 88 | $11,692 | $4,013 | 34.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 31 | 31 | $6,498 | $3,055 | 47.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 30 | 30 | $5,777 | $1,951 | 33.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 25 | 26 | $2,936 | $1,549 | 52.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 25 | 27 | $2,230 | $921.44 | 41.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 15 | 15 | $2,175 | $756.30 | 34.8% |
About Jodi Palmer, FNP
Jodi Palmer, FNP is a Nurse Practitioner healthcare provider based in Anthem, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2015. The National Provider Identifier (NPI) number assigned to this provider is 1578942165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jodi Palmer, FNP has received a total of $1,765 in payments from pharmaceutical and medical device companies, with $635.30 received in 2024. These payments were reported across 84 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,715).
As a Medicare-enrolled provider, Palmer has provided services to 1,548 Medicare beneficiaries, totaling 2,004 services with total Medicare billing of $70,349. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family
- Location Anthem, AZ
- Active Since 05/28/2015
- Last Updated 01/12/2016
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1578942165
Products in Payments
- Otezla (Drug) $197.09
- Saxenda (Drug) $158.71
- FARXIGA (Drug) $148.30
- Kerendia (Drug) $128.05
- BREZTRI (Drug) $115.34
- Cologuard Collection Kit (Device) $103.45
- TRELEGY ELLIPTA (Drug) $87.38
- Ozempic (Drug) $79.33
- REXULTI (Drug) $68.24
- AIRSUPRA (Drug) $64.54
- CREON (Drug) $59.73
- Impella (Device) $55.44
- NEXLETOL (Drug) $50.00
- Dexcom G6 Transmitter (Medical Supply) $49.11
- HETLIOZ (Drug) $39.51
- Wegovy (Drug) $39.41
- INSPIRE (Device) $35.39
- Rybelsus (Drug) $33.34
- PROCLAIM (Device) $28.87
- ZEPBOUND (Drug) $26.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.